April 15, 2025   Sweden
Direkt Studios: Strategic Positioning and Growth Outlook for Diamyd Medical
CEO Ulf Hannelius and board member Mark Atkinson are interviewed by Direkt Studios about the strategic positioning of Diamyd Medical, including the therapeutic platform, current and future indications, commercial opportunities, and upcoming milestones.

The broadcast is produced by Direkt Studios, an independent part of the editorial team at Nyhetsbyrån Direkt.
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research

GAD PRODUCTS